Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han-Kwang Yang

Showing results (361-370 of 425) with videos related to

Pageof 43
Sort By:
Experimental & Molecular Medicine|May 14, 2025
Cancer-associated fibroblast-derived fibulin-5 promotes epithelial-mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosisJinju Choi, Yoonjin Kwak, Miree Park, et al.
Gastroenterology|June 14, 2022
Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric MucosaJimin Min, Changqing Zhang, R Jarrett Bliton, et al.
The Lancet. Oncology|January 30, 2016
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialKazumasa Fujitani, Han-Kwang Yang, Junki Mizusawa, et al.
Biomedicines|September 28, 2021
CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer PatientsGabriela M Almeida, Carla Pereira, Ji-Hyeon Park, et al.
Korean Journal of Clinical Oncology|January 9, 2026
Patients participation in multidisciplinary management in gastric cancer: regulation comparison and expert survey among major countriesKyoyoung Park, Hyuk-Joon Lee, Seong-Ho Kong, et al.
Lancet (London, England)|January 10, 2012
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialYung-Jue Bang, Young-Woo Kim, Han-Kwang Yang, et al.
Cancer Medicine|March 14, 2023
Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatmentHyun Jung Kwon, Yujun Park, Soo Kyung Nam, et al.
NPJ Parkinson'S Disease|August 15, 2024
Diagnostic accuracy and predictors of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson's diseaseChaewon Shin, Seong-Ik Kim, Sung-Hye Park, et al.
The British Journal of Surgery|March 29, 2025
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre studySander J M van Hootegem, Margrietha van der Linde, Marcel A Schneider, et al.
Journal of Gastric Cancer|October 19, 2016
The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort StudyBang Wool Eom, Young-Woo Kim, Byung-Ho Nam, et al.
Pageof 43

Showing results (361-370 of 425) with videos related to

Sort By:
Pageof 43
Experimental & Molecular Medicine|May 14, 2025
Cancer-associated fibroblast-derived fibulin-5 promotes epithelial-mesenchymal transition in diffuse-type gastric cancer via cAMP response element-binding protein pathway, showing poor prognosisJinju Choi, Yoonjin Kwak, Miree Park, et al.
Gastroenterology|June 14, 2022
Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric MucosaJimin Min, Changqing Zhang, R Jarrett Bliton, et al.
The Lancet. Oncology|January 30, 2016
Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialKazumasa Fujitani, Han-Kwang Yang, Junki Mizusawa, et al.
Biomedicines|September 28, 2021
CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer PatientsGabriela M Almeida, Carla Pereira, Ji-Hyeon Park, et al.
Korean Journal of Clinical Oncology|January 9, 2026
Patients participation in multidisciplinary management in gastric cancer: regulation comparison and expert survey among major countriesKyoyoung Park, Hyuk-Joon Lee, Seong-Ho Kong, et al.
Lancet (London, England)|January 10, 2012
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialYung-Jue Bang, Young-Woo Kim, Han-Kwang Yang, et al.
Cancer Medicine|March 14, 2023
Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatmentHyun Jung Kwon, Yujun Park, Soo Kyung Nam, et al.
NPJ Parkinson'S Disease|August 15, 2024
Diagnostic accuracy and predictors of alpha-synuclein accumulation in the gastrointestinal tract of Parkinson's diseaseChaewon Shin, Seong-Ik Kim, Sung-Hye Park, et al.
The British Journal of Surgery|March 29, 2025
Impact of postoperative complications on clinical outcomes after gastrectomy for cancer: multicentre studySander J M van Hootegem, Margrietha van der Linde, Marcel A Schneider, et al.
Journal of Gastric Cancer|October 19, 2016
The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort StudyBang Wool Eom, Young-Woo Kim, Byung-Ho Nam, et al.
Pageof 43